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ABSTRACT

Viral, endoparasitoid and/or host genes that speci?cally
inhibit the immune response of insect pests, useful for

broadening the host range of insect viruses. Symbiont
viruses of insect pests are genetically modi?ed to express

immune-suppressing proteins or biologically active frag
ments thereof and, optionally toxins, to increase the virus

host range and/or improve the efficacy of insect pathogens.

14 Claims, 8 Drawing Sheets
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VIRAL AND INSECT GENES THAT INHIBIT
THE IMMUNE SYSTEM AND METHODS OF
USE THEREOF

nism of this immune suppression is not, hoWever, presently
knoWn but may involve disruption of the hemocyte cytosk

GOVERNMENT LICENSE RIGHTS

contained in the Wasp oviduct ?uid and venom. It is also

eleton.

Additional factors in immune system suppression may be
knoWn that insect venom, ovarian and viral proteins share

The US. Government has a paid-up license in this inven

certain epitopes and that one or more ovarian proteins

tion and the right in limited circumstances to require the

transiently inhibits the immune response (Webb and
Luckhart, Archives of Insect Biochemistry and Physiology,
26: 147 (1994)).

patent oWner to license others on reasonable terms as

provided for by the terms of Grant No. AI-33114-03
aWarded by the National Institutes of Health, Department of

It has been shoWn that oviduct proteins may, at least in

Human Services.

part, mediate the immunosuppressive effect observed in
some systems. Additionally, the effect can be generated by

FIELD OF THE INVENTION

The invention relates to the neW genes, particularly viral,

15

endoparasitic insect and insect host genes, encoding prod

nucleic acids) are thought to be involved in the suppression

ucts that speci?cally inhibit the insect immune response. The
invention further relates to methods of expanding the host
range of insect viruses and methods of biological control of

of the immune response in Venturia cansecens. (Schmidt et

al., Subcell. Biochem., 15: 91 (1989)). Certain VLP proteins
may be related to a host protein, designated p42, in this
system. Another report indicates interference of

plant insect pests using the genes of the invention. The
invention is thus useful, for example, in the biological
control of insect pests and, in particular, in the protection of
crops from insect damage.
BACKGROUND OF THE INVENTION

the injection of puri?ed polydnavirus particles and virus-like
particles (VLPs). For example, VLPs (Which are devoid of

plasmatocyte-dependent immune phenomena by
polydnavirus-rich calyx ?uid. (Davies et al., Cell and Tissue
Research, 251: 467 (1988)) It is conjectured that successful
25

Insects, like other animals, have effective immune sys
tems to combat both biotic and abiotic foreign invasion. It is

parasitism may require immunosuppression of the host to a
level that interferes With other cellular immune reactions in
addition to encapsulation.
Host cellular factors may also be involved in the immune

of interest, then, that certain insect species, the endoparasitic
insects, spend a part of their life cycle inside the body of

suppression in some cases. For example, a cellular immu

other insect hosts. Considerable effort has been expended

larval plasma of the armyWorm Pseua'aletia separata para
sitiZed With the Wasp Cotesia kariyai. The factor, Which

nosuppressive protein factor, ISP, has been isolated from the

investigating the mechanism by Which these endoparasitic
insects avoid the host immune system in this parasitic

suppresses encapsulation of foreign bodies, is suggested to

relationship.

be a 470 kDa hexamer composed of identical 82 kDa

Mechanisms of “immune evasion” include (1) avoidance
(e. g., by not coming into prolonged contact With the immune

35

system), (2) evading the immune system, for example, by
molecular mimicry, (3) blocking the immune recognition

subunits. (HayakaWa, J. Biol. Chem., 269:14536 (1994)).
Thus, depending upon the particular system studied, host,
parasite and/or virus factors may be involved in the sup

pression of the host immune system. (Vinson, Archives of
Insect Biochemistry and Physiology, 13: 1 (1990)). It is

system, (4) subversion of the host immune system, and (5)
suppression of the immune system. (Vinson, UCLA Sym
posia on Molecular and Cellular Biology, 112: 517 (1990)).

therefore believed that each of these sources may play a role

in host insect immune system suppression generally, and that

For large foreign bodies, in particular, encapsulation by the

there may be a cooperative effect betWeen factors Which

granulocytes and plasmatocytes of the hemolymph is a

alloW the immune system to be compromised suf?ciently for

common immune response.

parasitiZation.

It is currently thought that encapsulation results from a

45

The WHv1.0, WHv1.6 and VHv1.1 genes of Campoletis

sonorensis polydnavirus (CsPDV) have recently been

?rst recognition of the foreign body surface by the

cloned and sequenced. These genes are described as mem

granulocytes, Which then degranulate to release one or more
chemoattractant substances that are assumed to attract addi

bers of a polydnavirus “cysteine-rich” gene family. (Dib
Hajj et al., Proc. Natl. Acad. Sci. (USA) 90: 3765 (1993)).

tional granulocytes and plasmatocytes. The plasmatocytes
then attach to the foreign body, ?atten out and form a

It has been conjectured that these genes may play a role in

microtubule and micro?lament matrix, ultimately enclosing

preventing the recognition of foreign objects and/or the

the foreign body in several layers of cells. In some cases, the

normal response of components of the immune system.
(Summers et al., Proc. Natl. Acad. Sci. (USA) 92: 29
(1995)). Indeed, the VHv1.1 gene product of the C. sono
rensis polydnavirus has been implicated in the inhibition of
the cellular immune response. This 30 kDa protein is shoWn
by indirect immuno?uorescence to bind both granulocytes

inner layers of plasmatocytes melaniZe. Encapsulation thus
serves to isolate the foreign body in the insect.
One Well characteriZed parasitoid-host system in Which
there is immune system evasion is that of the endoparasitic
Wasp Campoletis sonorensis and its host, the tobacco bud
Worm Heliothis virescens. In investigating hoW immuno

55

and plasmatocytes and is thought to inhibit encapsulation.
(Li et al., J. Virol., 68: 7482 (1994)).
As parasitoid insects eventually kill their insect hosts, the

suppression is regulated in this system, it became apparent
that a group of Wasp viruses, knoWn generically as

parasitoids represent a natural biological means for control

polydnaviruses, play a role in the suppression of the host
immune system. It is believed that during oviposition, the

endoparasitic insect, for example C. sonorensis, injects not
only eggs but also polydnavirus and oviduct proteins.
Shortly thereafter, the host insect immune system begins to
shoW evidence of altered activity and the endoparasitoid
eggs remain free from encapsulation. The precise mecha

ling insect pests, in particular those pests responsible for
crop damage. Traditionally, such parasitoids have not pro
65

vided a highly effective strategy for insect control, in large
part because the host range of the parasitoids is limited.
It Would therefore be advantageous to provide methods
Whereby the host range of parasitoid insects could be

5,827,518
3

4

broadened, such that the parasitoids Would provide effective

DETAILED DESCRIPTION OF THE
INVENTION

biological control for a larger number of insect hosts.
It Would be a further advantage to identify speci?c virus,
parasitoid and/or host genes involved in the successful

Genes that disrupt the insect immune system are of

practical importance in the area of biological pest control.
Speci?cally, the insect immune system is thought to deter

suppression of the insect immune system by the endopara
sitoid. Such genes could then be used, through recombinant

mine the host range of the group of insect viruses knoWn as

DNA techniques, to generate genetically modi?ed insects,
viruses and/or plants, that express one or more immune

suppressing factors.
The invention provides these and other advantages, as

10

Will be apparent to those skilled in the art based on the
disclosure hereunder.

mance of insect viruses as a biological pest control means.
15

invention provides the VHv1.4 genomic DNA, derived from
the C. sonorensis polydnavirus, and the sequence of Which
is set forth in SEQ ID NO: 1. The invention further provides
a VHv1.4 cDNA (SEQ ID NO: 2), Which encodes the

VHv1.4 protein product (SEQ ID NO: 3) involved in insect
immune system suppression. The invention also provides
the SOPs cDNA (SEQ ID NO: 4) of Campoletis sonorensis
and the protein encoded thereby (SEQ ID NO: 5), also useful
in suppressing the insect immune system in the methods of
the invention. Each of these DNAs and protein is useful for
the expansion of viral host range.

system and thereby expand the virus host range Would

signi?cantly improve the commercial prospects and perfor

SUMMARY OF THE INVENTION

The invention ?rst provides a DNA useful for the sup
pression of an insect host immune system. In particular, the

baculoviruses. Additionally, virus host range is a major
factor in determining Whether a particular virus Will be of
commercial importance. Genes that suppress the immune

25

The invention further provides methods for expanding
parasitoid insect host range comprising:

Immune suppressive genes under the invention provide for
methods in Which viruses, for example baculoviruses, can be
used for expression, With the concomitant immune suppres
sion and expansion of the virus host range.
The endoparasitic Wasp Campoletis sonorensis injects a
polydnavirus into its host Heliothis virescens during ovipo
sition. Viral gene expression protects the Wasp egg and larva
from encapsulation by host hemocytes. The invention relates
to the isolation and puri?cation of genes involved in escap
ing the host immune response. As exemplary of the
invention, the VHv1.4 genomic and cDNA have been iso
lated from C. sonorensis polydnavirus. As shoWn beloW, the
VHv1.4 protein is involved in suppressing the immune
system of the insect host. This protein is further capable, by
means of its immune system targeting function, to broaden
the host range of the endoparasite and thereby provide an
ef?cient means of pest control.

providing one or more DNAs encoding an insect immune

suppressing factor, or a biologically active fragment

The current data indicates that the binding of immune

thereof, operably linked to one or more expression

suppressing proteins to granulocytes and plasmatocyte sur
faces is involved in immune suppression and disruption of
the hemocyte cytoskeleton. The binding of hemocytes has

signals,
inserting said DNA into the genome of an endoparasitic
insect virus, an endoparasitoid or a plant, and

35

expressing said DNA to provide for immune suppression
of one or more insect hosts,

Wherein the insect hosts are not a natural host for said

endoparasitic insect.
The invention additionally provides for genetically modi

been shoWn to occur in permissive and semi-permissive
hosts. Moreover, the binding additionally occurs in some,
but not all, non-permissive hosts. These results suggest that
the host range of endoparasitic insects is related to the
effectiveness by Which these insects suppress the immune

system of the potential host.
EXPERIMENTAL

?ed viruses, particularly polydnaviruses, endoparasitoid
insects and/or plants capable of expressing a DNA encoding

A. Isolation of the VHv1.4 cDNA

an immunosuppressive protein or polypeptide.

The invention also provides plasmids, vectors and,
especially, expression vectors operably linked to the DNA of

Insect rearing and viral DNA puri?cation from calyx ?uid
45

Were done as described (Krell et al., J. Virol. 43: 859

(1982)). For RNA analysis requiring parasitiZed H.

the invention.

virescens, 15 to 20 third-instar larvae Were parasitiZed by 8
to 10 female Wasps Within about 30 minutes. At the end of
this period, larvae Were designated as 0 hr p.p (post

The invention yet further provides a recombinant protein
encoded by a DNA, or biologically active fragments thereof,
Wherein said protein or fragment suppresses the immune

parasitiZation).

system of one or more insect hosts, as Well as methods of

broadening the host range of insect viruses and parasitoids

A lambda gt11 cDNA library Was constructed from

comprising applying the protein or fragment to plants,
Whereby said protein is ingested by said pests.
The invention further provides methods of protecting
crops, particularly commercially important crops, from

mRNA of parasitiZed H. virescens and screened by colony
hybridiZation using the VHv1.1 cDNA as a probe
55

damage by one or more insect pests.

(Sambrook et al. 1989). Positive hybridiZation plaque DNA
Was ampli?ed by polymerase chain reaction (PCR)
using
lambda
gt11
forWard
(5‘

GGTGGCGACGACTCCTGGAGC-3‘) (SEQ ID NO: 6)

BRIEF DESCRIPTION OF THE DRAWINGS

and reverse (5‘-GACACCAACTGGTAATG-3‘)) (SEQ ID

FIG. 1 depicts the genomic DNA sequence of the C.

NO: 7) primers (Tung et al. 1989). Ampli?cation reactions

sonorensis polydnavirus VHv1.4 DNA (SEQ ID NO: 1).
FIG. 2 depicts the predicted amino acid sequence (SEQ
ID NO: 3) encoded by the VHv1.4 cDNA sequence (SEQ ID

Were carried out in 1x PCR buffer (10 mM Tris-HCl, pH 9.0,

50 mM KCl), With 50 pM each dNTPs, 1.25 mM MgCl2, 0.5
pg of each of the primers, 5 pL phage suspension and 2.5

NO: 2).

units of Taq DNApolymerase. Phage DNA Was denatured at
94° C. for 2 min. and 35 ampli?cation cycles Were per

FIG. 3 depicts the C. sonorensis SOPs cDNA SEQ ID

NO: 4 and the protein product (SEQ ID NO: 5) encoded

thereby.
FIG. 4 schematically depicts the plasmid pSH V.

65

formed (94° C., 2 min., 55° C., 2 min., 72° C., 3 min.) in a
Model 480 DNA thermocycler (Perkin Elmer Cetus). The
ampli?ed DNA fragments Were digested With EcoRI and

5,827,518
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cloned in “BLUESCRIPT” II KS(—) (Stratagene) for
sequence analysis.

upstream of the translation initiation ATG. The three other
introns lie Within the coding sequence.
F. Inhibition of the Immune Response by the VHv1.4
Gene Product
To demonstrate that the VHv1.4 gene product inhibits
host immune response, the cDNA and genomic clone are
inserted into bacterial expression vectors operably linked to
transcription control signals. A suitable vector for such
expression is pET22b(+), Which alloWs the fusion With a 6x
histidine tag to facilitate puri?cation. Such construction is

To clone the 3‘ end of VHv1.4 cDNA, 0.5 pg of total RNA
from parasitiZed H. virescens larvae at 24 hr. p.p. Was

reverse transcribed using oligo(dT) primer

(GCACTTAACT17) (SEQ ID NO: 8). Reverse transcription
Was performed at 42° C. for 30 min. in 20 pL of reaction mix

containing 1>< cDNA synthesis buffer (50 mM Tris-HCl, pH
8.9, 20 mM KCl, 2.5 mM MgCl2, 200 pM of each dNTP, 10
mM DTT, 0.2 pg primer and 200 units MMLV reverse

10

transcriptase (Promega)). The reaction mixture Was digested

suitably made by attachment of, for example, EcoRI linkers

With 2 units of RNAse H at 42° C. for 10 min. One microliter
of the reverse transcription mixture Was removed for PCR

to the VHv1.4 DNA and insertion into EcoRI site of the

With oligo(dT) and 1.4 kb cDNA-speci?c primers, using 35
cycles of 94° C., 1 min., 48° C., 1 min., 72° C., 2 min. The

vector by standard procedures. The expressed product from
15

PCR product Was cloned in the pCR-TRAP vector

coli), expression of the fusion protein is induced With IPTG
and puri?ed from the bacterial lysates. The fusion protein

(GeneHunter) for sequence analysis.
B. Isolation of the VHv1.4 Genomic DNA
The viral genomic copy of the VHv1.4 gene Was cloned
from a 12.9 kb EcoRI fragment of SH V, contained in

can be engineered, Where desired, to contain a unique
20

pVE12.9 cloned in pBS (Dib-Hajj et al. 1993). This clone
Was used to screen a CsPDV PstI library in “BLUESCRIPT”

KS(—) to select an overlapping 7.9 kb clone (pVP7.9) that
hybridized to both termini of pVE12.9. Another CsPDV
Sau3A library made from partially digested viral DNA Was
probed With the 0.8 kb fragment of the 1.4 kb cDNA. Clones
hybridiZing to the probe Were re-screened by PCR With 1.4

kb-speci?c primers. Ampli?cation Was performed With the
GeneAmp 6000 system (Perkin Elmer Cetus) using the
folloWing protocol: 94° C., 2 min., 94° C., 30 sec., 55° C.,

the vector is thus a fusion that facilitates puri?cation.
After transformation of a suitable bacterial host, (e.g. E.

protease cleavage site at the fusion junction. For example, a
Factor Xa cleavage site may be used, alloWing isolation of
intact or nearly intact VHv1.4 protein. As is knoWn to the
skilled artisan, this puri?ed protein can also be used for
immuniZation to raise antibodies against one or more anti

25

genic determinants.
The VHv1.4 cDNA or genomic DNA may also suitably be
expressed in a baculovirus system. The recombinant DNA is
cloned into a suitable vector, for example pVL1393, and

cotransfected With the E2 strain of Autographa californica
30

30 sec., 72° C., 1 min., for 35 cycles. Overlapping SH V
genomic clones Were mapped With restriction enZymes.

nuclear polyhedrosis virus into Spodoptera frugipera'a (Sf9)
cells to produce a recombinant virus. This virus may then be

assayed according to standard procedures (Webb et al.

1990).

E. DNA Sequencing and Analysis
NASE” 2.0 kit (United States Biochemical) . Sequence data

To demonstrate the immunosuppressive function of the
VHv1.4 protein, Washed eggs are prepared from 20 chilled
C. sonorensis female Wasps. The eggs are suitably dissected
from Wasp ovaries about 5 days after mating. Eggs are

Were analyZed using the University of Wisconsin Genetics
Computer Group DNA analysis softWare for the VAX com

centrifugation (1500><g, 7 min.). Eggs are then resuspended

DNA sequences Were determined by the dideoxy chain

35

termination method (Sanger et al. 1977) using “SEQUE

puter (release 7.2).
The predicted amino acid sequence of the longest ORF of
the VHv1.4 cDNA insert is given (SEQ ID NO: 3). The
cDNA sequence is 1338 bp long, and the longest ORF
identi?ed is 966 nt from nucleotide 57 (relative to the 5‘ end
of the cDNA clone) to nucleotide 1022. The sequence
surrounding the ?rst methionine codon in the cDNA is

suspended in 1 mL of Pringle’s saline and collected by
40

in Pringle’s saline and pelleted about ?ve times to remove

CsPDV and ovarian proteins. Recombinant virus (104 PFU)
in a volume of about 1 pL is injected into chilled fourth
instar H. virescens larvae With a 10 pL Hamilton microsy
45

ringe. The E2 stain of Wild-type virus or a saline solution can
be injected into additional larva as controls to Which the

activity of the recombinant virus can be compared. Naturally

consistent With the translation initiation consensus sequence

parasitiZed insects may also be used as a control.

(KoZak 1983). A putative polyadenylation signal is located

TWenty four hours post injection, pretreated larvae are
injected With Washed Wasp eggs (8 to 12 eggs/larva) With a

15 nt upstream from the poly(A) tail.
The longest ORF in the 1.4 kb cDNA encodes a protein

50

?nely draWn glass capillary. The encapsulation response to

of 322 amino acids With a predicted molecular mass of 42

the eggs is then determined. In the absence of virus and

kDa. The N-terminal amino acid sequence is very hydro
phobic and encodes a signal peptide according to the rules
of von Heijne, indicating that this protein is destined either

eggs is seen at about 24 hours post injection. If, at 24 hours

ovarian proteins, a strong encapsulation response to parasite

post parasitiZation, one or more of the eggs had 100 or more
for insertion into the membrane or secretion. There are six 55 adherent hemocytes, covering at least one third of the egg,

potential N-glycosylation sites in the protein and, similar to

then the host is scored as immunoresponsive. If feWer than
100 hemocytes are adhered on all the eggs recovered, then
the insect is scored as immunosuppressed. These data can

the VHv1.1 cDNA, there are tWo complete cysteine motifs
(amino acids 40 to 80 and 277 to 317).
The genomic clone Was determined by Southern hybrid
iZation to reside on a 2.7 kb XhoI genomic fragment. This

then be analyZed by chi-square statistical analysis.
60

2.7 kb fragment Was sequenced, con?rming that the cDNA

is encoded by this genomic DNA fragment. Aputative TATA
box is located in the genomic DNA 42 bp upstream of the 5‘
end of the cDNA clone. Four introns 124, 186, 187 and 342
bp in length Were identi?ed in the genomic DNA. Splicing
signals are consistent With the consensus for eukaryotic
genes. Intron 1 is found in the 5‘ leader region, 27 bp

65

The above-described experiment demonstrates that the
VHv1.4 protein inhibits the host immune response. Thus,
vectors expressing the VHv1.4 protein, or biologically
active fragments thereof, and other toxic proteins may be
useful in biological pest control. For example, inclusion in
the vector of an expression cassette for scorpion toxin and/or
other toxins, coupled With the immune suppression of the
pest, alloWs for a faster and more ef?cient kill of the pests.

5,827,518
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It is thus another embodiment of the invention to have a

may also encode one or more toxic substances, to increase

the speed and ef?cacy of the insect kill.

vector, preferably a baculovirus vector, containing a DNA
Which encodes an immune-suppressing protein or fragment

In these and other embodiments of the invention, the
parasitoid host range is broadened to include non-natural
host insects. By “non-natural” it is meant that the host insect
is not the naturally-occurring host for the particular

thereof, preferably the VHv1.4 cDNA, genomic DNA, or a
biologically active fragment thereof, and one or more genes

encoding a polypeptide or protein possessing a toxic activity.
Asuitable vector for use in this embodiment of the invention

endoparasitoid insect.

is the above-mentioned pVL1393 baculovirus vector.
Expression of the immune-suppressing sequences in a

Additionally, vectors under the invention may also encode
a marker for the rapid identi?cation of recombinant virus,
endoparasite, host or plant. Such a marker may provide a

recombinant virus, a parasitoid, a host or a plant is used to

affect biological control of the insect pest.
In yet another embodiment of the invention, the VHv1.4
cDNA, genomic DNA or biologically active fragment
thereof, is introduced into plants to create transgenic plant
varieties. Such plants, When producing the VHv1.4 protein
or biologically active fragment thereof, become resistant to
insect pests. According to this embodiment of the invention,
a transgenic plant capable of expressing an immune sup
pressing protein or polypeptide, is made by any of the
knoWn techniques using the DNA of the invention. Insect
larva feeding on such transgenic plants become immune
suppressed and thus susceptible to a large variety of dis

10

visible result (e.g., [3-galactosidase, luciferase, etc.) or may
be either a positive or a negative selectable marker.

The invention is exempli?ed by the VHv1.4 gene of the
C. sonorensis/H. virescens parasitic system. It is by no
15

function analogously to the C. sonorensis polydnavirus in
suppressing the host immune response. Moreover, certain
toxins and oviduct proteins are also believed to have

immune suppressing function. Each of these immune sup
pressing proteins, Which may be related by a common

cysteine motif (Dib-Hajj et al., Proc. Natl. Acad. Sci. (USA)

eases.

90: 3765 (1993)), are Within the scope of the invention.

A further embodiment of the invention is directed to use

of the VHv1.4 protein, or a biologically active fragment

means meant, hoWever, to be restricted to this system. For
example, there are tens of thousands or insect species, many
if not all of Which are expected to contain viruses that

25

Representative insect species that may be biologically
controlled by the process of the invention include:

thereof, for direct application onto plants. In this
embodiment, the VHv1.4 protein is overexpressed, for

Autographica californica, Heliothis virescens, Heloithis
Zea, Spodoptera frugipera'a, Peria'roma saucia, Prode

example, in bacteria, yeast, plants, insect cells, etc., isolated

nia eridonia, Prodenia ornithogalli, Pseua'aletia

and puri?ed. In one preferred embodiment, the protein or

unipuncia, Spodoptera exigua, Trichoplusia ni, Agrotis

fragment thereof is produced as a fusion With an amino acid

ipsilon, Estigmene acrea, malacosoma pluviale,
Nomophila noctuella, Pieris rapae, Proa'enia prae?ca,
Ceramica picta, Dargida procincm, Feltia sp., Gra
pholithya molesta, Heliothis armigera, Heliothis

sequence that assists in puri?cation. Preferably, a poly
histidine linker is used for a N- or C-terminal fusion product,

thereby alloWing rapid isolation and puri?cation of the
fusion protein. Most preferably, the poly-histidine linker
comprises about 7 contiguous histidine residues and may be

assulta, Hymenia recurvalis, Lacinipolia stricta, Mis

35

elia sp, Morrisonia confusa, Neleucania sp., Neuris sp.,
Plusia sp., Ostrinia nubilalis, Vanessa atalanta and the
like.

removed by endoproteolytic enZymatic cleavage.
The recombinant protein so produced may be conve
niently lyophiliZed to increase storage life or, as one

alternative, may be kept in a buffered solution, for example,
phosphate buffered saline. The product so produced is then
applied to plants, preferably after reconstitution of the
lyophiliZed product in Water or buffered saline. In practice,
insect larva ingest the recombinant protein and become
immune suppressed, thereafter being susceptible to lethal
infections.
As examples of other genes useful in the practice of the
invention, mention is made to the C. sonorensis OPs 33

Similarly, representative endoparasitoids Which may be
genetically modi?ed or Which may carry genetically modi
?ed virus under the invention include those of the order

Hymenoptera, particularly of the families Braconidae and
Ichneumonidae.

As Will be appreciated by those skilled in the art, the
45

invention provides for protection of one or more crops. Most

notable as the commercially important crops protected are

corn (maiZe), sorghum, beet, cotton, tomato, tobacco,
sun?oWer, soybean, rapeseed, groundnuts, chick pea,
saf?oWer, beets, cabbage, broccoli and cauli?oWer and the

genes, in particular the SoPs gene (SEQ ID NO: 4), and the
C. sonorensis polydnavirus WHv1.0, WHv1.6, VHv1.1 and

like.

2.6 kb RNA genes, as Well as functionally related genes from

As previously noted, the invention as presently disclosed
is exempli?ed by the C. sonorensis polydnavirus VHv1.4

virus, endoparasitoids and hosts. FolloWing the disclosure
herein, other genes related to the above-mentioned genes can

gene and protein product, as Well as biologically active

be isolated by, for example, library hybridiZation, PCR and

fragments thereof. Such a biologically active fragment pref

reverse transcription technologies. Such genes are therefore
meant to be embraced Within the scope of the present
invention.

55

erably contains at least one of the above-mentioned cysteine

motifs. Another biologically active fragment, for example, is
the protein product produced devoid of the hydrophobic

The invention further is useful for increasing the host
range of endoparasitic pests. In this embodiment, a recom

N-terminal sequences and DNA encoding such a protein.
Additionally, a homolog of the DNAs and proteins of the

binantly engineered virus, preferably a baculovirus, is con
structed to express an immune suppressing protein, prefer
ably VHv1.4 protein, or a biologically active fragment
thereof. A variety of endoparasitic pests are then produced
Which are capable of expressing the recombinant virus.

invention are Within the scope of the claims appended
hereto. Such a DNA homolog, for example, is one that

Upon oviposition, the immune suppressing protein (e.g.,
VHv1.4 protein) is expressed, leading to the suppressing of
the host immune system. As above, such a recombinant virus

makes use of the degeneracy of the genetic code to provide
a DNA of differing sequence from that disclosed herein by
that at the same time encodes the same, or substantially the
65

same, protein product.
As discussed above, the VHv1.4 gene encodes tWo cys
teine motifs. Based upon these motifs, one of ordinary skill

5,827,518
9

10

in the art can design probes to search for other members of

such other genes are given above and include those analo

this gene family in other viruses, insect hosts and other
species (eg arachnids). Such genes can be screened for
immune suppressing activity, for example as detailed above,

gous immune-suppressing genes from other parasitoid/host
systems and other species under the invention. Such com
binations of genes may be encoded, for example, in a single
vector, on separate vectors, or incorporated into the virus,

and used in the methods under the invention in a fashion
analogous to the use of the VHv1.4 gene exempli?ed herein.
Such immune suppressing genes may also be used in com
bination under the practice of the invention, to create numer

parasitoid and/or plant genome.
The above examples are meant to be exemplary of the
invention, and should not be construed as a limitation to the

ous immune suppressing products for the control of insect

pests.

10

It is a further aspect of the invention, then, to use the

immune suppressing VHv1.4 gene in combination With
other genes that affect an immune-suppressing response.
When used in such a combination, the host range for a given
parasitoid may be even more greatly expanded. Examples of

claims appended hereto. Moreover, the scope and spirit of
the invention as de?ned in the claims is meant to encompass
those variants thereof Which are obvious to those of ordinary
skill in the art in light of the disclosure contained herein.
Publications and patents cited above are each incorpo

rated herein in their entirety by reference thereto.

SEQUENCE LISTING

( 1 ) GENERAL INFORMATION:
( i i i )NUMBER OF SEQUENCES: 8

( 2 ) INFORMATION FOR SEQ ID NO:1:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 2310 base pairs
( B ) TYPE: nucleic acid
( C ) STRANDEDNESS: double
( D ) TOPOLOGY: unknown

( i i )MOLECULE TYPE: DNA (genomic)
' i i )HYPOTHETICAL:NO
' v )ANTI-SENSE: N0

i ) ORIGINAL SOURCE:

( A ) ORGANISM: Campoletis sonorensis virus
( v i i )IMIVEEDIATE SOURCE:

( B ) CLONE: VHv1.4
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:1:
GCTATCGCGA

TACAATTTCC

AGCTAAATTA

TCGTTAGGTC

GTCCGGGTCA

GCTCGAACGA

GAGGCCAGCT

ACTGGGTGCT

TACATGTATA

AAAGCACAGT

CCCGCCCTCA

ACAATCCAGA

GTATTACTTA

TCGCGGCCTG

CGCGTCGGAC

AATTTTTTCA

TTGTAAGTAT

TTCATAAAAA

ATCCAATTTG

TTCGTAGATA

GTTGTGGACT

AATCCTTCTT

CGTAACCGTC

GAATGAAGGA

GCCATTTCAT

AATTAAATAC

AATGTTTTAT

TTGTTACTAT

TCGCAGATAA

TAAATCATAG

CATTACCTGG

ACCATGAAGT

TTTTGTGGTT

TGCACTGGTC

GCAGTGGTTA

CAGTGGCTGC

GCATCCTGTG

GTCGAGACAT

CAACTGAGAA

AGAGGCCGAC

GGGAAAACTT

CGCCCCAATG

CGAGCCAGGG

TGCATCGGCA

ATTACCAACC

TGTAAGTACA

TCATTGCTAG

CACTTTGTCA

ACAAACCATT

GGAGCATATG

CCTGCTGAAA

CTCTTTACCG

ACGAATGTGT

CGTTAGTGAG

ATGATGGAGA

TGTCTACTTT

ATATATTGGA

ATAGAATATC

TATACCTAAC

ATACCATGTC

AAATTCAATT

AAGATAATAT

TGTCTTGTAT

GTTTCAGTGC

ATTGAGTCGA

CGAAGCCCTG

CTGCCGACTT

GAAGATCGCA

CATCGGTGCA

ATTTGGACGT

AAAGAGTACA

TCTGTGATCG

ATTCTTCGGC

GGACTCTGTG

CCCCATTAGA

CGTCATAAAC

AACCTTACAC

TGTATAAAGA

ATTGAGTGCA

CAATTGAACG

AAACTAATTT

GGCGGAACTC

TCCAATCTGT

ATTTCCAAGG

TATAAAGCAC

ACGCTGGGAA

TCAAGCCAGA

ACCCAAGATA

GAAGACGCGG

GAAAAGTCGA

5,827,518
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12
-continued

GGAAGTCGTG

AAACAGAGTA

CGGACAACAT

GAAATTGAGT

ACCGAAGCCG

AACGTGAACC

TGGAGACAAG

ACAGTATCCG

GAACAGAAAA

CTGGGTACAA

TCCCCAGACA

CGGATTCGCC

TATTAACAAC

AAACCTGTAA

GTACATCATT

GTTAGCACTT

TGTCAACAAA

CCATTGGAGC

ATATGCCTGG

CTGAAACTCT

TTACCGACGA

ATATGTCGTA

AGTGAGATGA

TGGAGATGCC

TACTTTATAT

ATTGGAATAG

AATATCTATA

TCTAACATAC

CATGTCAAAT

TCAATTAAGA

TAATATTGTC

TTGTATGTTT

CAGTGCATTG

AGTCGAAGGA

GTCCCGCTGC

CGACTTGAAA

ATCGCACATT

GGTGCAATTT

GGACGTGAAG

AGGACATCTA

TGGTCGATTC

CTCGGCGGGA

TCTATGCTCC

ATTAATAGTC

GTTAACAACT

CCACACTGTA

TTTAGAATTG

AGTAAAGGAA

TGAACGAAAC

TAAATTGTCG

AATCTCAGCG

ATTGGTATAT

AGCAGCAGCT

GTAATCCCCA

TGCCGGAATT

CAAGCCAGAA

TCCAAGATAG

AAGATGAGCG

AAAATCCCCA

GAAGCCCCAG

AACTCGAGTC

ACAGTGCATC

CCAAATTATG

AACTGGTAAG

TAAATAATGG

ATACCACTTC

ATTATTCAAT

CGTTCAAGCA

TATGACTGAT

GGAACTCCCC

AACAAAATGT

ATGTTTTATG

CCACCACGCT

GAAACCCTCC

GAAGATGCTG

GCGACAGATG

CCTTTGACGA

TGAACGATTA

CAGCATATAT

TGGAATAGGC

ATCGTGTACT

TTTCCACATG

TCACGCCCTT

TAACATGTAT

TGAAGTAGAC

ATCGTCACGT

TTTATCTCTG

GGAGAGTCTG

TGAGCAATTT

CACGGGGTAC

ACTCTTAGTT

ATTCTCAATC

TGTCGTCGTG

GATCTTGTGA

ACTTGAACTA

CAT CAATGTC

ATTTTGTATA

TTTTCAGTGC

GTGAATTCGA

AGAGGCCGTG

TTGCTGGGAG

AATAAGCTGT

TCGCTGGTTC

ATCTAAACCC

CGTAATTTCG

TATGCGGTCT

ACACGGCCGA

AGCTACTGTT

CACCATTCGA

TGGCTAACCA

ATTGGATATT

CGCTGGAAGG

TCGACAGGTT

AAGGGAACAA

GAATCGATCA

AGAAGGAAGT

TTACGCTGTC

GACTTTTCAT

CAACAAGGAC

CACTTTTTCC

GTTTTTCAAC

TGAGCTAGAG

GTGGTTCTTG

TTTTATACGA

ATATTTTTTA

ATGTCTTTTG

TGTTGCATTA

AGCATTTTTT

GAAATTTTGT

CTTTCCTTAT

ATCAATAATT

TTAGGTTGCA

TGTCGTTGAA

AAACTATTTA

GTTTATTATA

AGAAGGAATA

ATGTAATATG

TTTCAAGATT

TTTTTTCAAT

AAAGAGTAAT

GATAATTAAA

( 2 ) INFORMATION FOR SEQ ID NO:2:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 1472 base pairs
( B ) TYPE: nucleic acid
( C ) STRANDEDNESS: double

( D )TOPOLOGY: unknown

A

i i ) MOLECULE TYPE: cDNA

( i i i )HYPOTHETICAL:NO

A

i X )FEATURE:

( A )NAME/KEY: CDS
( B )LOCATION: 190.1155

A

x i ) SEQUENCE DESCRIPTION: SEQ ID NO:2:

GCTATCGCGA

TACAATTTCC

AGCTAAATTA

TCGTTAGGTC

GTCCGGGTCA

GCTCGAACGA

60

GAGGCCAGCT

ACTGGGTGCT

TACATGTATA

AAAGCACAGT

CCCGCCCTCA

ACAATCCAGA

120

GTATTACTTA

TCGCGGCCTG

CGCGTCGGAC

AATTTTTTCA

TTATAATAAA

TCATAGCATT

180

ACCTGGACC

GTG
VaI

GCT
Ala
15

ATG
Met
1

GCG
AIa

AAG

TTT

TTG

TGG

TTT

GCA

CTG

Lys

Phe

Len

Trp

Ph

Ala

Len

CAT
His

e

GTC
VaI

5
CCT
Pro

GTG
Val

GTC
Val
20

GAG
GIu

ACA
Thr

TCA
Ser

ACT
Thr

GCA
Ala
10

GAG
Glu
25

GTG
Val

GTT
VaI

ACA
Thr

AAA

GAG

GCC

GAC

Lys

GI u

AIa

Asp

228

276

5,827,518
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16
-continued

TCTTTTGTGT

TGCATTAAGC

ATTTTTTGAA

ATTTTGTCTT

TCCTTATATC

AATAATTTTA

1375

GGTTGCATGT

CGTTGAAAAA

CTATTTAGTT

TATTATAAGA

AGGAATAATG

TAATATGTTT

1435

CAAGATTTTT

TTTCAATAAA

GAGTAATGAT

AATTAAA

1472

( 2 ) INFORMATION FOR SEQ ID NO:3:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 322 amino acids
( B )TYPE: amino acid

( D )TOPOLOGY: IineaI
' i ) MOLECULE TYPE: protein

i ) SEQUENCE DESCRIPTION: SEQ ID NO:3:
Ph

6

Ala

Th

Th

I

Th

m

Ln:

Ln:

H

00

I

Ph

w

As

in

Th

Ph

10 O
Th

Se
14 O
Th

Me

AI
15

Se
16 O

Th

Th

Ph

I

AI
20

Ph
21

As
22 O

AI
26
As
28

6

PI
29

Asn
295
Ph

6

GI
30

Th

5,827,518
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18
-continued

( 2 ) INFORMATION FOR SEQ ID NO:4:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 882 base pairs
( B ) TYPE: nucleic acid
( C ) STRANDEDNESS: double

( D )TOPOLOGY: unknown

A

i i ) MOLECULE TYPE: cDNA

( i i i )HYPOTHETICAL:NO

A

i v )ANTI-SENSE: NO

A

v i )ORIGINAL SOURCE:

( A ) ORGANISM: Campoletis sonorensis virns
( i X )FEATURE:

( A )NAME/KEY: CDS
( B )LOCATION: 127.319
( x i )SEQUENCE DESCRIPTION: SEQ ID NO:4:
GTCGAACTGT

ATCTCTAACG

ATCACAGTAG

CTCAACCCAA

ACTTTTCAAA

ATTTTCGCAA

AAATCTGTTT

TTTGGTGCTT

ATGTGTTGCG

TGTTCGTCTA

TAAAAACATC

AATTTGTAAA

CAATTG

ATG

TAC

AAA

TTT

GTT

TTG

GTG

ACG

CTT

CTG

AGC

TGT

GTG

CTG

Met

Tyr

Lys

Phe

Va I

Len

Va I

Thr

Len

Len

Ser

Cys

Va I

Len

1

5

10

335

GCC

CAA

GCG

AAT

CCG

CAG

GTG

TCG

CGC

CAT

GGT

CCC

GCT

GCT

GTT

GTA

AI a

GIn

AI a

Asn

Pro

GIn

Va I

Ser

Arg

Hi s

GI y

Pro

AI a

AI a

Va I

Va I

15

2O

25

3O

TCG
Ser

GAT
Asp

GCG
A1 a

AAT
Asn

CGA
Arg
35

ACG
Thr

GTT
Va I

CAT
Hi 5

CCT
Pro

CCA
Pro
4O

CCA
Pro

GCT
A1 a

CAA
GIn

AAC
Asn

CAC
Hi 5
45

GCC
A1 a

GAG
GIn

ATG
Me I

GCA
AI a

CGT
Arg
50

TTC
Phe

ATC
I I e

GTT
Va I

AAT
Asn

CAA
GIn
55

GCC
AI a

GAC
Asp

TGG
Trp

GCA
AI a

TCT
Se r
6O

CTG
Len

GCA
AI a

ACA

ATC

AGC

ACT

ATA

GAA

AAC

ATC

GCT

TCT

TAT

CCA

ATT

GCC

AGC

Thr

I I e

Ser

Thr

I I e

GIn

Asn

I I e

AI a

Ser

Tyr

Pro

I I e

AI a

Ser

65

7O

I I e

75

AAA

TCA

ATT

AGT

GAC

GGA

CCG

GGC

GGC

AAT

GGT

ACC

GGA

GAT

CCT

TAT

Lys

Ser

IIe

Ser

Asp

GIy

Pro

GIy

GIy

Asn

GIy

Thr

GIy

Asp

Pro

Tyr

80

85

9O

TTG

TTT

ATC

TCA

CCG

AGG

ACT

TTC

TCT

GGT

AGA

GAC

ATA

GTT

GCT

GAT

Len

Phe

IIe

Ser

Pro

Arg

Thr

Phe

Ser

GIy

Arg

Asp

IIe

VaI

AIa

Asp

95

100

105

110

TCG

CGA

GCG

AGT

CTC

GTC

ATC

TCC

TTG

GCT

CAG

GGT

GCC

TAC

TGC

AAG

Ser

Arg

AIa

Ser

Len

VaI

IIe

Ser

Len

Ala

GIn

GIy

AIa

Tyr

Cys

Lys

115

120

125

GAA

AAT

AAT

TAT

GAT

CCA

ATG

GAC

CCG

CGA

TGC

GGA

AGA

GTT

GTC

ATC

GIn

Asn

Asn

Tyr

Asp

Pro

Met

Asp

Pro

Arg

Cys

GI y

Arg

Va I

Va I

I I e

130

135

140

ACC

GGG

CCG

AGC

CGA

AAA

AAT

TGG

GGA

ATC

CAG

CCT

CCG

AAT

ACC

GCA

Thr

GIy

Pro

Ser

Arg

Lys

Asn

Trp

GIy

IIe

GIn

Pro

Pro

Asn

Thr

AIa

NCC
Xaa

TAT
Tyr

ATG
Me I

145
AGA
Arg

GCC
AI a
160

AGG
Arg

CCT

AGA

GAT

Pro

Arg

Asp

150
ACT
Thr

GCT
AI a

TTC
Phe

CAT

GGT

His

GIy

175

TTC
Phe
165

GGA
GI y

TTC

TAC

Phe

Tyr

155
CGT
Arg

CAT
Hi s

CCC
Pro

TTC

GCG

AAA

Phe

AIa

Lys

180

GCG
AI a
170

ATG
Me I

ATA

AAC

ATT

GAA

AAT

CTT

IIe

Asn

IIe

GIn

Asn

Len

185

190

CGT

GTT

CTT

GCA

TCA

TTT

GGT

CCA

TTC

CAC

GTG

GTC

TCC

GCT

CAA

GAT

Arg

VaI

Len

AIa

Ser

Phe

GIy

Pro

Phe

His

VaI

VaI

Ser

AIa

GIn

Asp

195

200

205

5,827,518
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-continued

TAC
Tyr

TAC
Tyr

AGT
Se r

TAT

ACG

AGT

Tyr

Thr

Ser

GCA
Al a
210

TCG
Ser

GTT
Va 1

GGA
GI y

GTA

CAA

ATT

GCA

Val

Gln

Ile

Ala

225
ATATTTGACT

CAG
Gln

CGA
Arg
215

CAA
Gl n

GAT
Asp

TGN
Xaa

CTT

CGG

TAATTTGAGA

Len

Arg

ATG
Me I

TAT
Tyr
220

TCA
Ser

CTA
Len

AAGTTCAATC

230
CTCCGAGGAA

CNCGATACTG

TTGAAATAAA

ATC

( 2 ) INFORMATION FOR SEQ ID NO:5:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 231 amino acids
( B )TYPE: amino acid

( D )TOPOLOGY: linear
( i i )MOLECULE TYPE: protein
( X i ) SEQUENCE DESCRIPTION: SEQ ID NO:5:
Me I
1

Tyr

Lys

Phe

Va 1
5

Len

130

Va 1

Thr

Len

Len
1O

Ser

135

Cys

Va 1

Len

14 O

155

18

( 2 ) INFORMATION FOR SEQ ID NO:6:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 21 base pairs
( B ) TYPE: nucleic acid

( c )STRANDEDNESS: single
( D )TOPOLOGY: linear
( i i ) MOLECULE TYPE: other nucleic acid
( A ) DESCRIPTION: /desc = “PRIIVEER’7

Al
15

16 O

190

5,827,518
21

22
-continued

( i i i )HYPOTHETICAL:NO
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:6:
GGTGGCGACG

ACTCCTGGAG

C

21

( 2 ) INFORMATION FOR SEQ ID NO:7:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 17 base pairs
( B ) TYPE: nucleic acid

( c )STRANDEDNESS: single
( D )TOPOLOGY: linear
( i i ) MOLECULE TYPE: other nucleic acid
( A ) DESCRIPTION: /desc = “PRIlVLER’7

( i i i )HYPOTHETICAL:NO
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:7:
GACACCAACT

GGTAATG

17

( 2 ) INFORMATION FOR SEQ ID NO:8:

( i )SEQUENCE CHARACTERISTICS:
( A ) LENGTH: 26 base pairs
( B ) TYPE: nucleic acid

( c )STRANDEDNESS: single
( D )TOPOLOGY: linear
( i i ) MOLECULE TYPE: other nucleic acid
( A ) DESCRIPTION: /desc = “PRIlVLER’7

( i i i )HYPOTHETICAL:NO
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:8:
GCACTTAACT

TTTTTTTTTT

TTTTTT

26

We claim:
1. A recombinant DNA comprising SEQ ID NO: 1 or a

7. A method of inhibiting the immune response of a host

insect comprising:

biologically active fragment or homolog thereof, Wherein

providing a bacterial expression vector or recombinant

the encoded product suppresses the immune system of one

baculovirus containing the DNA according to claim 5
operably linked to one or more expression signals; and
introducing the bacterial expression vector or recombi

or more insect species.

2. The recombinant DNA according to claim 1, Wherein
said DNA is isolated from the C. sonorensis polydnavirus.
3. A method of inhibiting the immune response of a host

insect comprising:
providing a bacterial expression vector or recombinant

baculovirus containing the DNA according to claim 1
operably linked to one or more expression signals; and
introducing the bacterial expression vector or recombi
nant baculovirus and one or more endoparasitoid insect

eggs into said host insect,

Whereby said DNA is expressed thereby inhibiting the
immune response of said host insect.

4. A vector comprising the recombinant DNA according
to claim 1.
5. A recombinant DNA encoding SEQ ID NO: 3 or a

biologically active fragment thereof, Wherein the encoded
product suppresses the immune system of one or more insect

species.
6. The recombinant DNA according to claim 5, Wherein
said DNA is isolated from the C. sonorensis polydnavirus.

nant virus baculovirus and one or more endoparasitoid
45

insect eggs into said host insect,

Whereby said DNA is expressed thereby inhibiting the
immune response of said host insect.

8. A vector comprising the recombinant DNA according
to claim 5.

9. The vector according to claim 8, further comprising at
least one DNA sequence encoding a toxin.

10. The method of claim 7, Wherein said DNA is isolated
from the C. sonorensis polydnavirus.
11. The method of claim 7, Wherein said insect eggs are
55 from C. sonorensis.

12. The method of claim 3, Wherein said DNA is isolated
from the C. sonorensis polydnavirus.
13. The method of claim 3, Wherein said insect eggs are
from C. sonorensis.

14. The vector according to claim 4, further comprising at
least one DNA sequence encoding a toxin.

